Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesGEHC -0.15%72 EV-to-OCF is 19.99 as of Aug. 15, 2026, which is 6% below its 10-year median of 21.32. GuruFocus rates GEHC with a GF Score™ of 72/100 and a GF Value™ of $84.16 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 75.15% on this metric.
The historical rank and industry rank for GE HealthCare Technologies's EV-to-OCF or its related term are showing as below:
GEHC'
s EV-to-OCF Range Over the Past 10 Years
Min: 16.18 Med: 21.32 Max: 25.13
Current: 19.99
During the past 7 years, the highest EV-to-OCF of GE HealthCare Technologies was 25.13. The lowest was 16.18. And the median was 21.32.
GEHC's EV-to-OCF is ranked worse than 75.15% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.94
vs GEHC: 19.99
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GE HealthCare Technologies (NAS:GEHC) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GE HealthCare Technologies's PE Ratio (TTM) for today is calculated as:
GE HealthCare Technologies's share price for today is $73.69.
GE HealthCare Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.360.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GE HealthCare Technologies EV-to-OCF Related Terms
GE HealthCare Technologies EV-to-OCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, GE HealthCare Technologies's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's EV-to-OCF falls into.
GE HealthCare Technologies's current Enterprise Value is $41,990 Mil.
GE HealthCare Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,101 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (GEHC) has a EV-to-OCF of 19.99 as of Aug. 15, 2026. This is near median its historical median of 21.32. Over the past decade, GE HealthCare Technologies' EV-to-OCF has ranged from 16.18 to 25.13. According to the industry distribution chart, GE HealthCare Technologies ranks #641 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 75.1%.
Is GE HealthCare Technologies' EV-to-OCF too high?
GE HealthCare Technologies' current EV-to-OCF of 19.99 is near median its 10-year median of 21.32. Over the past 10 years, this metric has ranged from a low of 16.18 to a high of 25.13. The Medical Devices & Instruments industry median EV-to-OCF is 7.94. GE HealthCare Technologies' value of 19.99 is 151.8% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #641 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' EV-to-OCF compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #641 out of 853 companies for EV-to-OCF. This places GE HealthCare Technologies in the lower half of its industry. The industry median EV-to-OCF is 7.94. GE HealthCare Technologies' value of 19.99 is 151.8% above this benchmark. Historically, GE HealthCare Technologies' own EV-to-OCF has ranged from 16.18 to 25.13 over the past decade. While the company's 10-year median is 21.32 vs. the industry median of 7.94, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.94, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current EV-to-OCF of 19.99 is 151.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current EV-to-OCF is 19.99, which is near median its own 10-year median of 21.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $84.16, compared to a current price of $73.69 — trading 12.4% below its estimated fair value. The current EV-to-OCF is 19.99, which is near median its 10-year median of 21.32 and 151.8% above the Medical Devices & Instruments industry median of 7.94. GE HealthCare Technologies' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For GE HealthCare Technologies (GEHC), the current EV-to-OCF is 19.99 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of $73.69 is trading 12.4% below its estimated GF Value™ of $84.16.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for GEHC:
EV-to-OCF: 19.99 (near median its 10-year median of 21.32)
GF Value™: $84.16 vs. price of $73.69 (12.4% below fair value)
Industry Position: 151.8% above the Medical Devices & Instruments median (#641 of 853)
No single metric tells the full story. See the GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
72GF Score
Get the complete analysis for GEHC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GEHC has been successfully added to your 
